NovoCure Limited (NVCR) Insider Trading
Over the last 3 months, NVCR insiders made 0 open-market buys and 7 sales, a net sale of -$325K (SEC Form 4). Over the last 6 months, 195 institutions increased and 140 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
7
Net (3m)
-$325.1K
Insider trades by month Buys Sells
May
Jun
Jul
Sep
Mar
Jun
Context3-month price +20.3%Institutions mixed (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 3, 2026 | LEUNG GABRIELdirector | Sell | 2,945 | $15.77 |
| Jun 3, 2026 | Stafford Kristindirector | Sell | 2,945 | $15.77 |
| Jun 3, 2026 | Ocean Allyson Jdirector | Sell | 2,945 | $15.77 |
| Jun 3, 2026 | VERNON W ANTHONYdirector | Sell | 2,945 | $15.77 |
| Jun 3, 2026 | HILLEMAN JERYL Ldirector | Sell | 2,945 | $15.77 |
| Jun 3, 2026 | Hung Daviddirector | Sell | 2,945 | $15.77 |
| Jun 3, 2026 | Scannell Timothy Jdirector | Sell | 2,945 | $15.77 |
| Apr 28, 2026 | VERNON W ANTHONYdirector | Option | 21,500 | $11.39 |
| Mar 5, 2026 | Cordova Ashleyofficer: Former Chief Executive Officer | Tax | 17,638 | $13.30 |
| Mar 5, 2026 | Paravasthu Mukundofficer: Chief Operating Officer | Sell | 43,246 | $13.77 |
| Mar 5, 2026 | Ben Arye Barakofficer: General Counsel | Grant | 50,125 | — |
| Mar 5, 2026 | Leupin Nicolasofficer: Former Chief Medical Officer | Sell | 1,100 | $13.31 |
| Mar 5, 2026 | Leonard Frank Xofficer: Chief Executive Officer | Grant | 216,388 | $13.30 |
| Mar 5, 2026 | Paravasthu Mukundofficer: Chief Operating Officer | Grant | 7,518 | $13.30 |
| Mar 5, 2026 | DOYLE WILLIAM Fdirector, officer: Executive Chairman | Grant | 200,284 | — |
| Mar 5, 2026 | Paravasthu Mukundofficer: Chief Operating Officer | Grant | 58,488 | $13.30 |
| Mar 5, 2026 | Leonard Frank Xofficer: Chief Executive Officer | Grant | 150,000 | — |
| Mar 5, 2026 | Paravasthu Mukundofficer: Chief Operating Officer | Sell | 5,377 | $13.31 |
| Mar 5, 2026 | Brackmann Christophofficer: Chief Financial Officer | Sell | 6,412 | $13.31 |
| Mar 5, 2026 | Leonard Frank Xofficer: Chief Executive Officer | Sell | 5,607 | $13.31 |
| Mar 5, 2026 | Puri Michal Nathofficer: Chief Human Resources Officer | Grant | 58,672 | $13.30 |
| Mar 5, 2026 | Puri Michal Nathofficer: Chief Human Resources Officer | Grant | 40,100 | — |
| Mar 5, 2026 | DOYLE WILLIAM Fdirector, officer: Executive Chairman | Grant | 200,000 | — |
| Mar 5, 2026 | DOYLE WILLIAM Fdirector, officer: Executive Chairman | Grant | 258,445 | $13.30 |
| Mar 5, 2026 | Weinberg Uriofficer: Chf Medical and Innovation Ofr | Grant | 73,340 | $13.30 |
| Mar 5, 2026 | Weinberg Uriofficer: Chf Medical and Innovation Ofr | Sell | 6,412 | $13.31 |
| Mar 5, 2026 | Puri Michal Nathofficer: Chief Human Resources Officer | Sell | 1,100 | $13.31 |
| Mar 5, 2026 | Brackmann Christophofficer: Chief Financial Officer | Grant | 55,137 | — |
| Mar 5, 2026 | Ben Arye Barakofficer: General Counsel | Grant | 73,340 | $13.30 |
| Mar 5, 2026 | DOYLE WILLIAM Fdirector, officer: Executive Chairman | Sell | 21,330 | $13.43 |
Source: NVCR SEC Form 4 filings, latest Jun 3, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their NVCR positions over the last 6 months (SEC Form 13F).
Increased
195
New positions
67
Reduced
140
Sold out
97
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 17.1M | May 15, 2026 |
| FMR LLC | Increased | 16.8M | Feb 17, 2026 |
| BLACKROCK, INC. | Reduced | 13.5M | Feb 12, 2026 |
| BLACKROCK, INC. | Reduced | 13.2M | May 13, 2026 |
| VANGUARD GROUP INC | Increased | 11.0M | Jan 29, 2026 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | Increased | 10.5M | May 14, 2026 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | Reduced | 8.5M | Feb 12, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 6.3M | May 8, 2026 |
| MORGAN STANLEY | Increased | 5.1M | Feb 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4.7M | May 15, 2026 |
| MORGAN STANLEY | Reduced | 4.5M | May 15, 2026 |
| WELLS FARGO & COMPANY/MN | Increased | 3.0M | May 11, 2026 |
| STATE STREET CORP | Reduced | 2.6M | Feb 13, 2026 |
| STATE STREET CORP | Reduced | 2.6M | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 2.5M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.